Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

For Autoimmune Ills, Biologics Bring Promise-And Problems.

Managed care (Langhorne, Pa.)·2017
Same author

Biosimilar Research Proceeds in Cancer, RA, and Hep B.

Managed care (Langhorne, Pa.)·2016
Same author

Biosimilars in Development Near End of Phase 3 Trials.

Managed care (Langhorne, Pa.)·2016
Same author

Digital Health Technology Adoption Depends On Tech Comfort Level, Willingness to Pay.

Managed care (Langhorne, Pa.)·2016
Same author

New Cancer Drugs Shine, but Costs May Dim Luster.

Managed care (Langhorne, Pa.)·2015
Same author

Sure, They're Cool, but Will Smart Wearables Ever Live Up to Their Potential?

Managed care (Langhorne, Pa.)·2015
Same journal

Big pharma moves into biologics.

Biotechnology healthcare·2013
Same journal

Study: High Copayments Cut Biodrug Use up to 21 Percent.

Biotechnology healthcare·2013
Same journal

Avian flu and the quest for immunity: not just chicken feed.

Biotechnology healthcare·2013
Same journal

Variety of Biotech Therapies, Uses Take Prominence Among ASCO Presentations.

Biotechnology healthcare·2013
Same journal

Opening the door to follow-on proteins?

Biotechnology healthcare·2013
Same journal

On specialty pharmaceuticals: reflections of a second-year medical student.

Biotechnology healthcare·2013
See all related articles

Related Experiment Video

Updated: May 14, 2026

Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
04:28

Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals

Published on: March 23, 2016

The off-label conundrum.

Katherine T Adams

    Biotechnology Healthcare
    |February 21, 2013
    PubMed
    Summary
    This summary is machine-generated.

    Off-label biologic use is rising due to treatment successes and patient demand. However, concerns about high costs, side effects, and legal issues persist for all stakeholders.

    More Related Videos

    A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
    09:22

    A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

    Published on: June 22, 2015

    Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
    04:04

    Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

    Published on: July 11, 2025

    Related Experiment Videos

    Last Updated: May 14, 2026

    Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
    04:28

    Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals

    Published on: March 23, 2016

    A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
    09:22

    A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning

    Published on: June 22, 2015

    Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
    04:04

    Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

    Published on: July 11, 2025

    Area of Science:

    • Pharmacology
    • Medical Economics
    • Regulatory Science

    Background:

    • The utilization of biologic therapies for unapproved indications (off-label use) is expanding.
    • This trend is driven by demonstrated treatment successes, increasing patient requests, and the emergence of novel therapeutic applications.

    Purpose of the Study:

    • To analyze the factors contributing to the rise in off-label biologic use.
    • To identify the primary concerns associated with this practice for various stakeholders.

    Main Methods:

    • Literature review of scientific evidence and medical opinions on biologic usage.
    • Analysis of economic and legal considerations in off-label drug prescription.

    Main Results:

    • Off-label biologic prescriptions are increasing.
    • Key concerns include high drug costs, potential adverse events, and legal liabilities.

    Conclusions:

    • While scientific evidence supports some off-label uses, significant financial and legal challenges remain.
    • Stakeholder alignment is needed to address the complexities of off-label biologic utilization.